Research to improve the quality of antivenom and the treatment system using antivenom (AMED Ato Group)

For medical professionals For medical

Co-researcher Professor Emeritus Joe Chiba of the Tokyo University of Science explains serum therapy for novel coronavirus infections in Nikkei Biotech (Part 2).

Dr. Chiba’s article on plasma therapy was published in Nikkei Biotech.

https://bio.nikkeibp.co.jp/atcl/news/p1/20/09/24/07426/?n_cid=nbpbto_mled_am